Ayşen Akalın

569 total citations
43 papers, 411 citations indexed

About

Ayşen Akalın is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ayşen Akalın has authored 43 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ayşen Akalın's work include Parathyroid Disorders and Treatments (7 papers), Medical Imaging and Pathology Studies (5 papers) and Bone health and treatments (5 papers). Ayşen Akalın is often cited by papers focused on Parathyroid Disorders and Treatments (7 papers), Medical Imaging and Pathology Studies (5 papers) and Bone health and treatments (5 papers). Ayşen Akalın collaborates with scholars based in Türkiye, United States and Australia. Ayşen Akalın's co-authors include Belgi̇n Efe, Özkan Alataş, Ömer Çolak, Nur Kebapçı, Tsieh Sun, Thomas Braun, Gökhan Temïz, Nevbahar Akçar, Mahmut Arabul and Canan Demirüstü and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and European Respiratory Journal.

In The Last Decade

Ayşen Akalın

35 papers receiving 392 citations

Peers

Ayşen Akalın

EDM

CCM

SURGE

ONCOL

Asterios Karagiannis Greece

Yuichiro Takeuchi Japan

Wenli Cheng China

Muammer Kara Türkiye

Lorenzo Gasperoni Italy

Sutin Sriussadaporn Thailand

Amelia P. Bailey United States

Hannah Forde Ireland

Miyase Bayraktar Türkiye

Xiaoya Zheng China

Asterios Karagiannis Greece

Ayşen Akalın

158 ×0.9

EDM

63 ×0.8

68 ×0.9

CCM

141 ×2.1

SURGE

29 ×0.5

ONCOL

Citations per year, relative to Ayşen Akalın Ayşen Akalın (= 1×) peers Asterios Karagiannis

Countries citing papers authored by Ayşen Akalın

Since Specialization

Citations

This map shows the geographic impact of Ayşen Akalın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşen Akalın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşen Akalın more than expected).

Fields of papers citing papers by Ayşen Akalın

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşen Akalın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşen Akalın. The network helps show where Ayşen Akalın may publish in the future.

Co-authorship network of co-authors of Ayşen Akalın

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşen Akalın. A scholar is included among the top collaborators of Ayşen Akalın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşen Akalın. Ayşen Akalın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kebapçı, Nur, et al.. (2025). Prognostic significance of Lin28A protein expression in papillary thyroid carcinoma. Indian Journal of Pathology and Microbiology. 68(3). 486–491.

Akalın, Ayşen, et al.. (2025). Intestinal Microbiota Composition in Patients with Type 2 Diabetes and Effects of Oral Antidiabetics. Journal of Clinical Medicine. 14(8). 2786–2786.

Akalın, Ayşen, et al.. (2023). Bone turnover markers and bone mineral density in patients with type 2 diabetes. The European Research Journal. 9(2). 301–308.

Akalın, Ayşen, et al.. (2022). Can non-functional adrenal incidentaloma be ranked among cardiovascular risk factors?. The European Research Journal. 8(6). 747–754. 2 indexed citations

Akalın, Ayşen, et al.. (2022). The Association of Serum Osteocalcin Levels with Metabolic Parameters and Inflammation in Postmenopausal Women with Metabolic Syndrome. Metabolic Syndrome and Related Disorders. 20(4). 219–223. 5 indexed citations

Akalın, Ayşen, et al.. (2021). Effect of hyperparathyroidism on coagulation: a global assessment by modified rotation thromboelastogram (ROTEM). TURKISH JOURNAL OF MEDICAL SCIENCES. 51(6). 2897–2902. 3 indexed citations

Onbaşı, Kevser, et al.. (2016). Hypoglobulinemia and Nonsecretory Myeloma as a Rare Cause of Osteoporosis in a Young Man. SHILAP Revista de lepidopterología. 20(2). 61–62. 1 indexed citations

Akalın, Ayşen, et al.. (2016). The Effect of Hyperparathyroid State on Platelet Functions and Bone Loss. Turkish Journal of Hematology. 33(4). 293–298. 5 indexed citations

Çiftçi, Gülşen Akalın, et al.. (2015). The effects of atorvastatin on antioxidant/antiinflammatory propertiesof HDLs in hypercholesterolemics. TURKISH JOURNAL OF MEDICAL SCIENCES. 45(2). 345–351. 14 indexed citations

10.

Arıkan, Hülya, Ebru Çalık-Kütükçü, Melda Sağlam, et al.. (2014). C-reactive protein: Its correlations with pulmonary function, physical capacity and anthropometric measurements in patients with metabolic syndrome. European Respiratory Journal. 44(Suppl 58). P4326–P4326. 1 indexed citations

11.

Akpınar, Aslı, Ayşen Akalın, & Harun Uysal. (2013). Probiyotiklerin Atopik Dermatit Üzerine Etkisi. Akademik Gıda. 11(1). 83–87. 1 indexed citations

12.

Kebapçı, Nur, et al.. (2010). Primary hyperparathyroidism at pregnancy. 22. 1 indexed citations

13.

Akalın, Ayşen, et al.. (2010). Lipid profle and levels of homocysteine, leptin, fbrinogen and C-reactive protein in hyperthyroid patients before and after treatment. 37(1). 1–7. 1 indexed citations

14.

Kanbak, Güngör, et al.. (2010). Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 5(1). 7–11. 17 indexed citations

15.

Özden, Hilmi, et al.. (2009). Comparative Evaluation of the Foot Measurements of Women Who Presented to the Obesity Outpatient Clinic in Eskişehir Osmangazi University. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(5). 1253–1259. 2 indexed citations

16.

Akalın, Ayşen, Özkan Alataş, & Ömer Çolak. (2008). Relation of plasma homocysteine levels to atherosclerotic vascular disease and inflammation markers in type 2 diabetic patients. European Journal of Endocrinology. 158(1). 47–52. 34 indexed citations

17.

Akalın, Ayşen, et al.. (2006). A case of primary pigmented micronodular hyperplasia as a cause of Cushing syndrome. 11. 1 indexed citations

18.

Ünal, Gülfem & Ayşen Akalın. (2006). Koroner Kalp Hastalığında Süt ve Ürünlerinin Önemi. DergiPark (Istanbul University). 31(5). 259–266.

19.

Değirmenci, İrfan, Nur Kebapçı, Belgi̇n Efe, et al.. (2005). Frequency of angiotensin-converting enzyme gene polymorphism in Turkish type 2 diabetic patients. International Journal of Clinical Practice. 59(10). 1137–1142. 36 indexed citations

20.

Akalın, Ayşen, et al.. (1999). Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clinical Biochemistry. 32(5). 363–367. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact